Integrative analysis based on survival associated co-expression gene modules for predicting Neuroblastoma patients’ survival time

BACKGROUND: More than 90% of neuroblastoma patients are cured in the low-risk group while only less than 50% for those with high-risk disease can be cured. Since the high-risk patients still have poor outcomes, we need more accurate stratification to establish an individualized precise treatment pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yatong, Ye, Xiufen, Cheng, Jun, Zhang, Siyuan, Feng, Weixing, Han, Zhi, Zhang, Jie, Huang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375203/
https://www.ncbi.nlm.nih.gov/pubmed/30760313
http://dx.doi.org/10.1186/s13062-018-0229-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375203/
https://www.ncbi.nlm.nih.gov/pubmed/30760313
http://dx.doi.org/10.1186/s13062-018-0229-2

Ejemplares similares